Wojciech Dyszkiewicz

Wojciech Dyszkiewicz

Auto-generated profile, based on publicly available information

Wojciech Dyszkiewicz

Department of Thoracic Surgery, Poznan University of Medical Sciences, Poznan, Poland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
BSBartosz Kazimierz Słowikowski
Bartosz Kazimierz Słowikowski
BGBartłomiej Gałęcki
Bartłomiej Gałęcki
WDWojciech Dyszkiewicz
Wojciech Dyszkiewicz
PJPaweł Jagodziński
Paweł Jagodziński

17 September 2008 in Advances in Respiratory Medicine
Verified
Journal Article
Open access
PDF file
MKMariusz Kasprzyk
Mariusz Kasprzyk
WDWojciech Dyszkiewicz
Wojciech Dyszkiewicz
DZDamian Zwaruń
Damian Zwaruń
KLKinga Leśniewska
Kinga Leśniewska
Krzysztof WiktorowiczKrzysztof Wiktorowicz
Krzysztof Wiktorowicz
Introduction: The aim of the study was to assess quantitative acute phase protein (APP) level changes in patients with non-small cell lung cancer (NSCLC) subjected to radical resections, as well as their influence on long-term survival. We analysed the correlation between quantitative APP changes and the histological type of the carcinoma, as well as the TNM stage and grade. Materials and methods: The study group comprised 46 patients subjected to surgical treatment of NSCLC during the period between 2003 and 2004. Average patient age amounted to 61 years (ranging between 45 and 77 years). The most frequent histological types of cancer were: squamous cell lung cancer (24 patients) and adenocarcinoma (17 patients). The majority of patients were diagnosed with stage II B (15 patients) and III A (14 patients). We evaluated the levels of the following APP: C-reactive protein (CRP), α1-acid glycoprotein (AGP), α1-antichymotrypsin (ACT), α1-antitrypsin (AT), α2-macroglobulin (M), ceruloplasmin (Cp), haptoglobin (Hp), and transferrin (Tf) by means of rocket immunoelectrophoresis (Laurell’s method). Results: The level of AT was significantly higher in patients with adenocarcinoma, as compared to other histological types of cancer. In the case of patients with squamous cell lung cancer, significantly higher M and Cp levels were observed. We found no correlation between the APP level and tumour grading. The levels of five APP: CRP, AGP, ACT, M and Cp were significantly higher in the group of patients with T3 or T4 category, while N1 or N2 patients presented with significantly higher concentrations of AT, CRP and Hp. Multivariate analysis confirmed the influence of the following factors on long-term survival: N stage, histological type of cancer and preoperative serum levels of AGP and Hp. Conclusions: The serum concentration of some acute phase proteins can correlate with the more aggressive clinical course of non-small cell lung cancer (NSCLC). Patients with adenocarcinoma and local lymph node metastases present with significantly higher levels of AT. Thus, it seems that the elevated preoperative levels of AGP and Hp might unfavourably influence long-term survival. The above-mentioned proteins might prove useful as prognostic factors when assessing the risk of neoplastic recurrence following surgical management.

1 April 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
AKAgnieszka Klupczynska-Gabryszak
Agnieszka Klupczynska-Gabryszak
PDPaweł Dereziński
Paweł Dereziński
JMJan Matysiak
Jan Matysiak
WDWojciech Dyszkiewicz
Wojciech Dyszkiewicz
MKMariusz Kasprzyk
Mariusz Kasprzyk
ZKZenon J. Kokot
Zenon J. Kokot

1 January 2022 in Polish Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
DZDominika Zielinska
Dominika Zielinska
CPCezary Piwkowski
Cezary Piwkowski
Piotr GabryelPiotr Gabryel
Piotr Gabryel
WDWojciech Dyszkiewicz
Wojciech Dyszkiewicz
Primary thymic carcinomas are very rare tumors. Their incidence is estimated around 1 to 3 cases per 10 million inhabitants. In this group, lymphoepithelioma-like carcinoma occurs (LELC) in 5–32% and the prognosis of advanced cases is poor. A 17-year-old man was admitted to the hospital...

4 January 2019 in Journal of Medical Science
Verified
Journal Article
Open access
AKAgnieszka Klupczynska-Gabryszak
Agnieszka Klupczynska-Gabryszak
MKMariusz Kasprzyk
Mariusz Kasprzyk
WDWojciech Dyszkiewicz
Wojciech Dyszkiewicz
MGMarcin Grabicki
Marcin Grabicki
HBHalina Batura-Gabryel
Halina Batura-Gabryel
JMJan Matysiak
Jan Matysiak
The project entitled “Study of serum metabolic profiles of patients with non-small cell lung cancer with special emphasis on the smoking status of patients” is a study based on metabolomics, which is the latest of the “omics” technologies and involves a comprehensive analysis of small molecule metabolites of a specific biological sample. High-throughput and sensitive analytical techniques used in metabolomic investigations are powerful tools in the field of oncology and aids understanding what is happening in cancer cells and searching for new cancer markers. The aim of the project is to determine whether lung cancer patients have a distinct serum metabolic profile and whether this profile is associated with patients’ smoking status. The application of liquid chromatography-high-resolution mass spectrometry-based methodology along with advanced statistical methods will enable to select potential molecules that can be useful in early lung cancer detection.